Cargando…

Effects of statin use on the response duration to androgen deprivation therapy in metastatic prostate cancer

PURPOSE: To determine whether statin use delays the development of castration-resistant prostate cancer (CRPC) in patients with metastatic prostate cancer treated with androgen deprivation therapy (ADT). MATERIALS AND METHODS: A total of 171 patients with metastatic prostate cancer at the time of di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Jaeyoon, Lee, Chunwoo, Lee, Chanwoo, Kwon, Taekmin, You, Dalsan, Jeong, In Gab, Hong, Jun Hyuk, Ahn, Hanjong, Kim, Choung-Soo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565897/ https://www.ncbi.nlm.nih.gov/pubmed/26366275 http://dx.doi.org/10.4111/kju.2015.56.9.630

Ejemplares similares

Clinical features and prognosis of prostate cancer with high-grade prostatic intraepithelial neoplasia
por: Lee, Donghyun, et al.
Publicado: (2015)

Comparison of Renal Function between Robot-Assisted and Open Partial Nephrectomy as Determined by Tc 99m-DTPA Renal Scintigraphy
por: Lee, Chanwoo, et al.
Publicado: (2016)

Prevalence and clinical significance of incidental (18)F-fluoro-2-deoxyglucose uptake in prostate
por: Kwon, Taekmin, et al.
Publicado: (2015)

Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice
por: Song, Geehyun, et al.
Publicado: (2013)

Histologic Variability and Diverse Oncologic Outcomes of Prostate Sarcomas
por: Sohn, Mooyoung, et al.
Publicado: (2014)

Clinicopathological Features of Prostate Ductal Carcinoma: Matching Analysis and Comparison with Prostate Acinar Carcinoma
por: Kim, Aram, et al.
Publicado: (2015)

Factors associated with testosterone recovery after androgen deprivation therapy in patients with prostate cancer
por: Nam, Wook, et al.
Publicado: (2018)

Androgen deprivation therapy during and after post-prostatectomy radiotherapy in patients with prostate cancer: a case control study
por: Kim, Myong, et al.
Publicado: (2018)

Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy
por: Lee, Chunwoo, et al.
Publicado: (2015)

Long-Term Oncologic Outcomes after Radical Cystectomy for Bladder Cancer at a Single Institution
por: Kwon, Taekmin, et al.
Publicado: (2014)

Discrimination of local recurrence after radical prostatectomy: value of diffusion-weighted magnetic resonance imaging
por: Kwon, Taekmin, et al.
Publicado: (2018)

Incidence of Benign Results After Laparoscopic Radical Nephroureterectomy
por: Hong, Sungwoo, et al.
Publicado: (2014)

Validation of the 2009 TNM Classification for Renal Cell Carcinoma: Comparison with the 2002 TNM Classification by Concordance Index
por: Lee, Chunwoo, et al.
Publicado: (2011)

KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway
por: You, Dalsan, et al.
Publicado: (2015)

Correction: KML001 Induces Apoptosis and Autophagic Cell Death in Prostate Cancer Cells via Oxidative Stress Pathway
por: You, Dalsan, et al.
Publicado: (2019)

Prognosis of Prostate Cancer With Other Primary Malignancies
por: Lim, Ju Hyun, et al.
Publicado: (2014)

Safety of Megestrol Acetate in Palliating Anorexia-Cachexia Syndrome in Patients with Castration-Resistant Prostate Cancer
por: Hong, Sungwoo, et al.
Publicado: (2013)

Is Bladder Tumor Location Associated with Prostate Cancer Detection after Intravesical Bacillus Calmette-Guérin Instillation?
por: Hong, Sungwoo, et al.
Publicado: (2014)

Prognostic impact of preoperative statin use after radical nephroureterectomy for upper urinary tract urothelial carcinoma
por: Lim, Ju Hyun, et al.
Publicado: (2015)

The association between serum lipid profile and the prostate cancer risk and aggressiveness
por: Suh, Jungyo, et al.
Publicado: (2023)

The Type of Nephrectomy Has Little Effect on Overall Survival or Cardiac Events in Patients of 70 Years and Older With Localized Clinical T1 Stage Renal Masses
por: Kyung, Yoon Soo, et al.
Publicado: (2014)

Clinicopathological features of Xp11.2 translocation renal cell carcinoma
por: Lim, Bumjin, et al.
Publicado: (2015)

Retropubic Versus Robot-Assisted Laparoscopic Prostatectomy for Prostate Cancer: A Comparative Study of Postoperative Complications
por: Ryu, Jeman, et al.
Publicado: (2013)

Does Radical Cystectomy Improve Overall Survival in Octogenarians with Muscle-Invasive Bladder Cancer?
por: Yoo, Sangjun, et al.
Publicado: (2011)

Efficacy and safety of degarelix in Korean patients with prostate cancer requiring androgen deprivation therapy: Open-label multicenter phase III study
por: You, Dalsan, et al.
Publicado: (2015)

The curative effect of androgen deprivation therapy alone is insufficient in high-risk prostate cancer
por: Choi, Se Young, et al.
Publicado: (2021)

Does epithelioid angiomyolipoma have poorer prognosis, compared with classic angiomyolipoma?
por: Lee, Wonchul, et al.
Publicado: (2018)

Nomogram using transrectal ultrasound-derived information predicting the detection of high grade prostate cancer on initial biopsy
por: Jeong, In Gab, et al.
Publicado: (2013)

Changes in Prostate Cancer Aggressiveness over a 12-Year Period in Korea
por: Kim, Doejung, et al.
Publicado: (2012)

Cause of Mortality after Radical Prostatectomy and the Impact of Comorbidity in Men with Prostate Cancer: A Multi-institutional Study in Korea
por: Pak, Sahyun, et al.
Publicado: (2020)

Preserving Renal Function through Partial Nephrectomy Depends on Tumor Complexity in T1b Renal Tumors
por: Yoo, Sangjun, et al.
Publicado: (2017)

Role of Radical Prostatectomy for High-Risk Prostate Cancer
por: You, Dalsan, et al.
Publicado: (2010)

Is Intravesical Bacillus Calmette-Guérin Therapy Superior to Chemotherapy for Intermediate-risk Non-muscle-invasive Bladder Cancer?: An Ongoing Debate
por: Han, Kyung-Sik, et al.
Publicado: (2015)

Phase I/IIa trial of androgen deprivation therapy, external beam radiotherapy, and stereotactic body radiotherapy boost for high-risk prostate cancer (ADEBAR)
por: Kim, Yeon Joo, et al.
Publicado: (2020)

Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer
por: Pak, Sahyun, et al.
Publicado: (2019)

Transition From Hand-Assisted to Pure Laparoscopic Donor Nephrectomy
por: You, Dalsan, et al.
Publicado: (2015)

Clinical effect of abiraterone acetate in Korean patients with metastatic castration-resistant prostate cancer according to duration of androgen deprivation therapy
por: Kim, Ki Bom, et al.
Publicado: (2015)

Impact of Adjuvant Androgen-Deprivation Therapy on Disease Progression in Patients with Node-Positive Prostate Cancer
por: Park, Sejun, et al.
Publicado: (2011)

Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer
por: Fujimoto, Naohiro, et al.
Publicado: (2011)

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
por: Kim, Yeon Joo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p194nfk5rrpigf2239ado84eif